Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study

Our previous study reported the favorable short-term outcome and good tolerance of integrating oxaliplatin into capecitabine-based (XELOX regimen) preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). The present study reported the long-term oncological outcome of this phas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Peng, Jianhong, Lin, Junzhong, Zeng, Zhifan, Wu, Xiaojun, Chen, Gong, Li, Liren, Lu, Zhenhai, Ding, Peirong, Wan, Desen, Pan, Zhizhong
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5649637/
https://ncbi.nlm.nih.gov/pubmed/29085451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6764
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars